| ［1］ |
Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 65.
|
| ［2］ |
Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: A review of the literature[J]. Cancer, 2009, 115(15): 3379–3391.
|
| ［3］ |
Zou M, Sheng J, Ruan M, et al. Perineural invasion confers poorer clinical outcomes in patients with T1/T2 intrahepatic cholangiocarcinoma: A single center, retrospective cohort study[J]. J Gastrointest Oncol, 2023, 14(6): 2500–2510.
|
| ［4］ |
Zhang Z, Lv ZG, Lu M, et al. Nerve-tumor crosstalk in tumor microenvironment: from tumor initiation and progression to clinical implications[J]. Biochim Biophys Acta Rev Cancer, 2024, 1879(4): 189121.
|
| ［5］ |
Tan X, Sivakumar S, Bednarsch J, et al. Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma[J]. Oncogene, 2021, 40(5): 899–908.
|
| ［6］ |
Guo Y, Gil Z. The role of extracellular vesicles in cancer-nerve crosstalk of the peripheral nervous system[J]. Cells, 2022, 11(8): 1294.
|
| ［7］ |
Chen MM, Gao Q, Ning H, et al. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer[J]. Cancer Cell, 2025, 43(9): 1656–1676, e1610.
|
| ［8］ |
Xue M, Zhu Y, Jiang Y, et al. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment[J]. Nat Commun, 2023, 14(1): 4600.
|
| ［9］ |
Batsakis JG. Nerves and neurotropic carcinomas[J]. Ann Otol Rhinol Laryngol, 1985, 94(4 Pt 1): 426–427.
|
| ［10］ |
Chaturvedi HT, Chaturvedi C. Hybrid peripheral nerve sheath tumours-A review[J]. J Oral Maxillofac Pathol, 2024, 28(4): 651–656.
|
| ［11］ |
Tereshenko V, Maierhofer U, Dotzauer DC, et al. Newly identified axon types of the facial nerve unveil supplemental neural pathways in the innervation of the face[J]. J Adv Res, 2023, 44: 135–147.
|
| ［12］ |
Doran S, Whiriskey R, Sheehy N, et al. Perineural tumour spread in head and neck cancer: A pictorial review[J]. Clin Radiol, 2024, 79(10): 749–756.
|
| ［13］ |
Peng YT, Zhou CY, Lin P, et al. Preoperative ultrasound radiomics signatures for noninvasive evaluation of biological characteristics of intrahepatic cholangiocarcinoma[J]. Acad Radiol, 2020, 27(6): 785–797.
|
| ［14］ |
Lin Y, Liu Z, Li J, et al. Predicting perineural invasion of intrahepatic cholangiocarcinoma based on CT: A multicenter study[J]. Abdom Radiol (NY), 2025. Online ahead of print.
|
| ［15］ |
Qi Z, Yuan H, Li Q, et al. An MRI-based fusion model for preoperative prediction of perineural invasion status in patients with intrahepatic cholangiocarcinoma[J]. World J Surg Oncol, 2025, 23(1): 164.
|
| ［16］ |
Liebl F, Demir IE, Rosenberg R, et al. The severity of neural invasion is associated with shortened survival in colon cancer[J]. Clin Cancer Res, 2013, 19(1): 50–61.
|
| ［17］ |
Ceyhan GO, Liebl F, Maak M, et al. The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy[J]. Ann Surg, 2010, 252(5): 797–804.
|
| ［18］ |
Zhang Z, Zhou Y, Hu K, et al. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: A retrospective cohort study[J]. BMC Cancer, 2020, 20(1): 270.
|
| ［19］ |
Meng XL, Lu JC, Zeng HY, et al. The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion[J]. Hepatol Int, 2023, 17(1): 63–76.
|
| ［20］ |
Chandra P, Song Y, Drill E, et al. Intrahepatic cholangiocarcinoma: recurrence patterns, genomics, and survival[J]. JCO Precis Oncol, 2025, 9: e2500402.
|
| ［21］ |
Kami S, Kojima M, Kudo M, et al. Clinicopathological significance and prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: A single-center, retrospective study[J]. Hum Pathol, 2025, 166: 105952.
|
| ［22］ |
Suzuki M, Takahashi T, Ouchi K, et al. Perineural tumor invasion and its relation with the lymphogenous spread in human and experimental carcinoma of bile duct. A computer-aided 3-D reconstruction study[J]. Tohoku J Exp Med, 1994, 172(1): 17–28.
|
| ［23］ |
Shen FZ, Zhang BY, Feng YJ, et al. Current research in perineural invasion of cholangiocarcinoma[J]. J Exp Clin Cancer Res, 2010, 29(1): 24.
|
| ［24］ |
Baruch EN, Gleber-Netto FO, Nagarajan P, et al. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy[J]. Nature, 2025, 646(8084): 462–473.
|
| ［25］ |
Gu J, Xu W, Peng C, et al. Perineural invasion is related to p38 mitogen-activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer[J]. J Cell Biochem, 2019, 120(7): 11775–11783.
|
| ［26］ |
Huang S, Zhu J, Yu L, et al. Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities[J]. Mol Cancer, 2025, 24(1): 133.
|
| ［27］ |
Fu Y, Shen K, Wang H, et al. Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis[J]. Signal Transduct Target Ther, 2024, 9(1): 63.
|
| ［28］ |
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis[J]. J Pain Symptom Manage, 2016, 51(6): 1070–1090. e1079.
|
| ［29］ |
Bennett MI, Rayment C, Hjermstad M, et al. Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review[J]. Pain, 2012, 153(2): 359–365.
|
| ［30］ |
Koulouris AI, Banim P, Hart AR. Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments[J]. Dig Dis Sci, 2017, 62(4): 861–870.
|
| ［31］ |
Yeh CF, Li WY, Chu PY, et al. Pretreatment pain predicts perineural invasion in oral squamous cell carcinoma: A prospective study[J]. Oral Oncol, 2016, 61: 115–119.
|
| ［32］ |
Takei Y, Laskey R. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease[J]. Trends Mol Med, 2008, 14(9): 381–388.
|
| ［33］ |
Ye Y, Dang D, Zhang J, et al. Nerve growth factor links oral cancer progression, pain, and cachexia[J]. Mol Cancer Ther, 2011, 10(9): 1667–1676.
|
| ［34］ |
Xu J, Zhu MD, Zhang X, et al. NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice[J]. J Neuroinflammation, 2014, 11: 38.
|
| ［35］ |
Wang K, Gu Y, Liao Y, et al. PD-1 blockade inhibits osteoclast formation and murine bone cancer pain[J]. J Clin Invest, 2020, 130(7): 3603–3620.
|
| ［36］ |
Xu C, Zhao B, Xu L, et al. CXCR1 participates in bone cancer pain induced by Walker 256 breast cancer cells in female rats[J]. Mol Pain, 2022, 18: 17448069221135743.
|
| ［37］ |
Swarm RA, Paice JA, Anghelescu DL, et al. Adult cancer pain, Version 3. 2019, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2019, 17(8): 977–1007.
|
| ［38］ |
Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era[J]. CA Cancer J Clin, 2018, 68(3): 182–196.
|
| ［39］ |
Jia SN, Wen FX, Gong TT, et al. A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers[J]. Int J Radiat Biol, 2020, 96(3): 383–389.
|
| ［40］ |
Taveggia C, Feltri ML. Beyond wrapping: canonical and noncanonical functions of Schwann cells[J]. Annu Rev Neurosci, 2022, 45: 561–580.
|
| ［41］ |
Fujii-Nishimura Y, Yamazaki K, Masugi Y, et al. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells[J]. Pathol Int, 2018, 68(4): 214–223.
|
| ［42］ |
Zu Z, Zhang C, Shi J, et al. Single-cell analysis reveals that GFAP(+) dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate/HMGB1 axis[J]. Cell Death Dis, 2025, 16(1): 215.
|
| ［43］ |
Wong FC, Merker SR, Bauer L, et al. Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migration[J]. Br J Cancer, 2025, 132(4): 326–339.
|
| ［44］ |
Han S, Wang D, Huang Y, et al. A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer[J]. J Exp Clin Cancer Res, 2022, 41(1): 348.
|
| ［45］ |
Kim HS, Noh YK, Min KW, et al. Cancer-associated fibroblasts together with a decline in CD8+ T cells predict a worse prognosis for breast cancer patients[J]. Ann Surg Oncol, 2024, 31(3): 2114–2126.
|
| ［46］ |
Shen T, Li Y, Wang D, et al. YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts[J]. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(12): 166540.
|
| ［47］ |
Ge F, Zeng C, Wang J, et al. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis[J]. Biochim Biophys Acta Mol Basis Dis, 2024, 1870(1): 166852.
|
| ［48］ |
Xu J, Ding L, Mei J, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments[J]. Signal Transduct Target Ther, 2025, 10(1): 268.
|
| ［49］ |
Zeng L, Guo Y, Liang J, et al. Perineural invasion and TAMs in pancreatic ductal adenocarcinomas: review of the original pathology reports using immunohistochemical enhancement and relationships with clinicopathological features[J]. J Cancer, 2014, 5(9): 754–760.
|
| ［50］ |
Cavel O, Shomron O, Shabtay A, et al. Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor[J]. Cancer Res, 2012, 72(22): 5733–5743.
|
| ［51］ |
Mu W, Wang Z, Zöller M. Ping-pong-tumor and host in pancreatic cancer progression[J]. Front Oncol, 2019, 9: 1359.
|
| ［52］ |
Zhang B, Guo X, Huang L, et al. Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma[J]. Br J Cancer, 2024, 130(4): 542–554.
|
| ［53］ |
Bakst RL, Xiong H, Chen CH, et al. Inflammatory monocytes promote perineural invasion via CCL2-mediated recruitment and cathepsin B expression[J]. Cancer Res, 2017, 77(22): 6400–6414.
|
| ［54］ |
Cheng K, Liu L, Gong M, et al. Steroid receptor coactivator-1 drives tumor-associated macrophage reprogramming by mediating MMP12 transcription in pancreatic cancer perineural invasion[J]. Adv Sci (Weinh), 2025, 12(45): e16575.
|
| ［55］ |
Zheng Z, Li X, Chen G, et al. Transcriptome analyses reveal new insights on key determinants of perineural invasion in high-grade serous ovarian cancer[J]. Front Cell Dev Biol, 2023, 11: 1109710.
|
| ［56］ |
Linedale R, Schmidt C, King BT, et al. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients[J]. PLoS One, 2017, 12(4): e0175755.
|
| ［57］ |
Ji F, Chen H, Li H, et al. A subcellular spatial atlas illuminates the microenvironmental remodeling of perineural invasion in distal cholangiocarcinoma[J]. J Hematol Oncol, 2026, 19(1): 6.
|
| ［58］ |
Zhao CM, Hayakawa Y, Kodama Y, et al. Denervation suppresses gastric tumorigenesis[J]. Sci Transl Med, 2014, 6(250): 250ra115.
|
| ［59］ |
Pinho-Ribeiro FA, Baddal B, Haarsma R, et al. Blocking neuronal signaling to immune cells treats streptococcal invasive infection[J]. Cell, 2018, 173(5): 1083–1097, e1022.
|
| ［60］ |
Yang MW, Tao LY, Jiang YS, et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma[J]. Cancer Res, 2020, 80(10): 1991–2003.
|
| ［61］ |
Darragh LB, Nguyen A, Pham TT, et al. Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs[J]. Med, 2024, 5(3): 254–270, e1-e8.
|